Federal Appeals Court Decision Will Keep Regeneron/Sanofi Drug At Center Of Patent Dispute On Market, For Now 0 09.02.2017 00:49 «FOX Business» (foxbusiness.com) A federal appeals court temporarily stopped another judge's decision that would have forced Regeneron and Sanofi to stop selling cholesterol drug Praluent. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
